Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(33%)

Phase Distribution

Ph phase_3
1
33%
Ph phase_4
1
33%
Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

unknown133%
not_yet_recruiting133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_4

Progesterone Preeclampsia

NCT07448597
unknownphase_3

Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day

NCT04897269
terminatednot_applicable

Comparison of Day 19 and Day 20 Artificial FET

NCT02788097

Clinical Trials (3)

Showing 3 of 3 trials
NCT07448597Phase 4

Progesterone Preeclampsia

Not Yet Recruiting
NCT04897269Phase 3

Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day

Unknown
NCT02788097Not Applicable

Comparison of Day 19 and Day 20 Artificial FET

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3